Related references
Note: Only part of the references are listed.Circulating microbiome in blood of different circulatory compartments
Robert Schierwagen et al.
GUT (2019)
Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease
Francesca Romana Ponziani et al.
HEPATOLOGY (2019)
Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma
Zhigang Ren et al.
GUT (2019)
A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease
Cyrielle Caussy et al.
NATURE COMMUNICATIONS (2019)
FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis
Marcel Sorribas et al.
JOURNAL OF HEPATOLOGY (2019)
Gut Microbiome: Profound Implications for Diet and Disease
Ronald D. Hills et al.
NUTRIENTS (2019)
Alcohol or Gut Microbiota: Who Is the Guilty?
Marica Meroni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The role of the microbiome in NAFLD and NASH
Aleksandra A. Kolodziejczyk et al.
EMBO MOLECULAR MEDICINE (2019)
Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature
Ivana Milosevic et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics
Jiezhong Chen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Non-alcoholic fatty liver disease - A global public health perspective
Zobair M. Younossi
JOURNAL OF HEPATOLOGY (2019)
Alcohol, liver disease and the gut microbiota
Jasmohan S. Bajaj
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Effect of a Multistrain Probiotic on Cognitive Function and Risk of Falls in Patients With Cirrhosis: A Randomized Trial
Eva Roman et al.
HEPATOLOGY COMMUNICATIONS (2019)
Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer
Yongzhi Yang et al.
THERANOSTICS (2019)
The Intestinal Microbiome in Nonalcoholic Fatty Liver Disease
Puneet Puri et al.
CLINICS IN LIVER DISEASE (2018)
Gut-liver axis alterations in alcoholic liver disease: Are bile acids the answer?
Jasmohan S. Bajaj et al.
HEPATOLOGY (2018)
Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis
Teresa Garcia-Lezana et al.
HEPATOLOGY (2018)
Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease
Stefano Bibbo et al.
MEDIATORS OF INFLAMMATION (2018)
Systematic review and meta-analysis of controlled intervention studies on the effectiveness of long-chain omega-3 fatty acids in patients with nonalcoholic fatty liver disease
Kathy Musa-Veloso et al.
NUTRITION REVIEWS (2018)
Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis
Jian-Zhong Ye et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
The Association of Gut Microbiota with Nonalcoholic Steatohepatitis in Thais
Abhasnee Sobhonslidsuk et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Akkermansia muciniphila can reduce the damage of gluco/lipotoxicity, oxidative stress and inflammation, and normalize intestine microbiota in streptozotocin-induced diabetic rats
Ling Zhang et al.
PATHOGENS AND DISEASE (2018)
Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches
Antonella Borrelli et al.
REDOX BIOLOGY (2018)
Genetic and Epigenetic Modifiers of Alcoholic Liver Disease
Marica Meroni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis
Paola Dongiovanni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD
Taylor K. Soderborg et al.
NATURE COMMUNICATIONS (2018)
Protective role of nano-selenium-enriched Bifidobacterium longum in delaying the onset of streptozotocin-induced diabetes
Yan Lin et al.
ROYAL SOCIETY OPEN SCIENCE (2018)
Gut Microbiota Profiling of Pediatric Nonalcoholic Fatty Liver Disease and Obese Patients Unveiled by an Integrated Meta-omics-Based Approach
Federica Del Chierico et al.
HEPATOLOGY (2017)
Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease
Oscar Chavez-Talavera et al.
GASTROENTEROLOGY (2017)
NLRP3 Deletion Inhibits the Non-alcoholic Steatohepatitis Development and Inflammation in Kupffer Cells Induced by Palmitic Acid
Can Cai et al.
INFLAMMATION (2017)
A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease
Paola Dongiovanni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Modulation of the gut microbiota impacts nonalcoholic fatty liver disease: a potential role for bile acids
Aafke W. F. Janssen et al.
JOURNAL OF LIPID RESEARCH (2017)
Influence of diet on the gut microbiome and implications for human health
Rasnik K. Singh et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2017)
Microbial Ecology along the Gastrointestinal Tract
Ethan T. Hillman et al.
MICROBES AND ENVIRONMENTS (2017)
Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier
Da Zhou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Animal Models of Nonalcoholic Fatty Liver Disease-A Starter's Guide
Mikhail A. Van Herck et al.
NUTRIENTS (2017)
Effects of Probiotics, Prebiotics, and Synbiotics on Human Health
Paulina Markowiak et al.
NUTRIENTS (2017)
Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease
Rohit Loomba et al.
CELL METABOLISM (2017)
Nonalcoholic fatty liver disease: Roles of the gut and the liver and metabolic modulation by some dietary factors and especially long-chain n-3 PUFA
Jacques Delarue et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2016)
Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis
A. Horvath et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota
Sena Bluemel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2016)
Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial Translocation
Lirui Wang et al.
CELL HOST & MICROBE (2016)
Metagenomics, Metatranscriptomics, and Metabolomics Approaches for Microbiome Analysis
Vanessa Aguiar-Pulido et al.
EVOLUTIONARY BIOINFORMATICS (2016)
The Severity of Nonalcoholic Fatty Liver Disease Is Associated With Gut Dysbiosis and Shift in the Metabolic Function of the Gut Microbiota
Jerome Boursier et al.
HEPATOLOGY (2016)
Efficacy of probiotics in non-alcoholic fatty liver disease in adult and children: A meta-analysis of randomized controlled trials
Xiaolin Gao et al.
HEPATOLOGY RESEARCH (2016)
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Elena Buzzetti et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
The role of the gut microbiota in NAFLD
Christopher Leung et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Impact of the gut microbiota on inflammation, obesity, and metabolic disease
Claire L. Boulange et al.
GENOME MEDICINE (2016)
Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut
Audrey Riviere et al.
FRONTIERS IN MICROBIOLOGY (2016)
Western diet induces a shift in microbiota composition enhancing susceptibility to Adherent-Invasive E. coli infection and intestinal inflammation
Allison Agus et al.
SCIENTIFIC REPORTS (2016)
Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-alcoholic Fatty Liver Disease
Baohong Wang et al.
SCIENTIFIC REPORTS (2016)
Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet
Mariana Verdelho Machado et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Novel role of TLR4 in NAFLD development: Modulation of metabolic enzymes expression
Darkiane Fernandes Ferreira et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2015)
Gut-liver axis, nutrition, and non-alcoholic fatty liver disease
Irina A. Kirpich et al.
CLINICAL BIOCHEMISTRY (2015)
Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis
Brian C. Ferslew et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States
Robert J. Wong et al.
GASTROENTEROLOGY (2015)
CX3CR1 is a gatekeeper for intestinal barrier integrity in mice: Limiting steatohepatitis by maintaining intestinal homeostasis
Kai Markus Schneider et al.
HEPATOLOGY (2015)
Heat Killed Lactobacillus reuteri GMNL-263 Reduces Fibrosis Effects on the Liver and Heart in High Fat Diet-Hamsters via TGF-β Suppression
Wei-Jen Ting et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
NAFLD: A multisystem disease
Christopher D. Byrne et al.
JOURNAL OF HEPATOLOGY (2015)
Implication of Gut Microbiota in Nonalcoholic Fatty Liver Disease
Jerome Boursier et al.
PLOS PATHOGENS (2015)
Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis
Paola Dongiovanni et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Gut Microbiota and Hepatocellular Carcinoma
Xuemei Tao et al.
GASTROINTESTINAL TUMORS (2015)
Effective treatment of hypertension by recombinant Lactobacillus plantarum expressing angiotensin converting enzyme inhibitory peptide
Guilian Yang et al.
MICROBIAL CELL FACTORIES (2015)
Randomised clinical trial: the beneficial effects of VSL# 3 in obese children with non-alcoholic steatohepatitis
A. Alisi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis
J. S. Bajaj et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Preventing non-alcoholic fatty liver disease through Lactobacillus johnsonii BS15 by attenuating inflammation and mitochondrial injury and improving gut environment in obese mice
Jinge Xin et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2014)
Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity
Valentina Giorgio et al.
DIGESTIVE AND LIVER DISEASE (2014)
Interactions Between the Intestinal Microbiome and Liver Diseases
Bernd Schnabl et al.
GASTROENTEROLOGY (2014)
Western diet induces dysbiosis with increased E coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation
Margarita Martinez-Medina et al.
GUT (2014)
Alterations of the human gut microbiome in liver cirrhosis
Nan Qin et al.
NATURE (2014)
A Model of Metabolic Syndrome and Related Diseases with Intestinal Endotoxemia in Rats Fed a High Fat and High Sucrose Diet
Xin Zhou et al.
PLOS ONE (2014)
Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease
Giulia Paolella et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Role of the gut microbiota in inflammatory bowel disease pathogenesis: What have we learnt in the past 10 years?
Georgina L. Hold et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Fructose Induced Endotoxemia in Pediatric Nonalcoholic Fatty Liver Disease
Ran Jin et al.
INTERNATIONAL JOURNAL OF HEPATOLOGY (2014)
Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease
Maitreyi Raman et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice
Tiphaine Le Roy et al.
GUT (2013)
Intestinal Microbiota in Patients With Nonalcoholic Fatty Liver Disease
Marialena Mouzaki et al.
HEPATOLOGY (2013)
Characterization of Gut Microbiomes in Nonalcoholic Steatohepatitis (NASH) Patients: A Connection Between Endogenous Alcohol and NASH
Lixin Zhu et al.
HEPATOLOGY (2013)
Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function
Johannie Du Plessis et al.
JOURNAL OF HEPATOLOGY (2013)
Obesity-induced microbial metabolite promotes HCC
Katrina Ray
Nature Reviews Gastroenterology & Hepatology (2013)
Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats
Feng-Ching Hsieh et al.
NUTRITION & METABOLISM (2013)
Is butyrate the link between diet, intestinal microbiota and obesity-related metabolic diseases?
L. K. Brahe et al.
OBESITY REVIEWS (2013)
Butyrate-Producing Probiotics Reduce Nonalcoholic Fatty Liver Disease Progression in Rats: New Insight into the Probiotics for the Gut-Liver Axis
Hitoshi Endo et al.
PLOS ONE (2013)
Molecular Characterization of the Fecal Microbiota in Patients with Nonalcoholic Steatohepatitis - A Longitudinal Study
Vincent Wai-Sun Wong et al.
PLOS ONE (2013)
Effects of probiotics on nonalcoholic fatty liver disease: A meta-analysis
Yan-Yan Ma et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study
Vincent Wai-Sun Wong et al.
ANNALS OF HEPATOLOGY (2013)
Toll-like receptors 1-9 are elevated in livers with fructose-induced hepatic steatosis
Sabine Wagnerberger et al.
BRITISH JOURNAL OF NUTRITION (2012)
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Dianne H. Dapito et al.
CANCER CELL (2012)
Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis
Michele Malaguarnera et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Altered intestinal tight junctions' expression in patients with liver cirrhosis: a pathogenetic mechanism of intestinal hyperpermeability
Stelios F. Assimakopoulos et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2012)
Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model
Ren-ying Xu et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2012)
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Jorge Henao-Mejia et al.
NATURE (2012)
16S rRNA Gene Pyrosequencing Reveals Bacterial Dysbiosis in the Duodenum of Dogs with Idiopathic Inflammatory Bowel Disease
Jan S. Suchodolski et al.
PLOS ONE (2012)
VSL#3 Resets Insulin Signaling and Protects against NASH and Atherosclerosis in a Model of Genetic Dyslipidemia and Intestinal Inflammation
Andrea Mencarelli et al.
PLOS ONE (2012)
Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity
Patrice D. Cani et al.
GUT MICROBES (2012)
The Human Microbiome Project in 2011 and Beyond
Lita M. Proctor
CELL HOST & MICROBE (2011)
The Bile Acid Membrane Receptor TGR5: A Valuable Metabolic Target
Thijs W. H. Pols et al.
DIGESTIVE DISEASES (2011)
Effects of Lactobacillus rhamnosus Strain GG in Pediatric Obesity-related Liver Disease
Pietro Vajro et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2011)
Protective effects of Lactobacillus paracasei F19 in a rat model of oxidative and metabolic hepatic injury
Gerardo Nardone et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
Molecular Characterisation of the Faecal Microbiota in Patients with Type II Diabetes
Xiaokang Wu et al.
CURRENT MICROBIOLOGY (2010)
Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism
Sylvie Rabot et al.
FASEB JOURNAL (2010)
Endotoxin Accumulation Prevents Carcinogen-Induced Apoptosis and Promotes Liver Tumorigenesis in Rodents
Le-Xing Yu et al.
HEPATOLOGY (2010)
The Role of Intestinal Endotoxin in Liver Injury: A Long and Evolving History
James P. Nolan
HEPATOLOGY (2010)
Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Nadja Larsen et al.
PLOS ONE (2010)
High-Fat Diet: Bacteria Interactions Promote Intestinal Inflammation Which Precedes and Correlates with Obesity and Insulin Resistance in Mouse
Shengli Ding et al.
PLOS ONE (2010)
VSL#3 Probiotic Treatment Attenuates Fibrosis Without Changes in Steatohepatitis in a Diet-Induced Nonalcoholic Steatohepatitis Model in Mice
Arumugam Velayudham et al.
HEPATOLOGY (2009)
Increased Intestinal Permeability and Tight Junction Alterations in Nonalcoholic Fatty Liver Disease
Luca Miele et al.
HEPATOLOGY (2009)
Probiotics Reduce the Inflammatory Response Induced by a High-Fat Diet in the Liver of Young Rats
Emanuela Esposito et al.
JOURNAL OF NUTRITION (2009)
Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome
Peter J. Turnbaugh et al.
CELL HOST & MICROBE (2008)
Specific Microbiota Direct the Differentiation of IL-17-Producing T-Helper Cells in the Mucosa of the Small Intestine
Ivaylo I. Ivanov et al.
CELL HOST & MICROBE (2008)
Bile acid levels are increased in the liver of patients with steatohepatitis
Marcia M. Aranha et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2008)
Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells
Xiong Ma et al.
JOURNAL OF HEPATOLOGY (2008)
Evolution of mammals and their gut microbes
Ruth E. Ley et al.
SCIENCE (2008)
Imbalance in the composition of the duodenal microbiota of children with coeliac disease
Inrnaculada Nadal et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2007)
The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects
Anna Kassinen et al.
GASTROENTEROLOGY (2007)
Resolution of nonalcoholic steatohepatits after gastric bypass surgery
Xiuli Liu et al.
OBESITY SURGERY (2007)
Increased intestinal permeability in obese mice:: new evidence in the pathogenesis of nonalcoholic steatohepatitis
Paola Brun et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
Fredrik Backhed et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells
C. Caballero-Franco et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats
Hariom Yadav et al.
NUTRITION (2007)
Microbial ecology - Human gut microbes associated with obesity
Ruth E. Ley et al.
NATURE (2006)
An obesity-associated gut microbiome with increased capacity for energy harvest
Peter J. Turnbaugh et al.
NATURE (2006)
Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice
Hui-Young Lee et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2006)
Obesity alters gut microbial ecology
RE Ley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases
C Loguercio et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2005)
Diversity of the human intestinal microbial flora
PB Eckburg et al.
SCIENCE (2005)
Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease
ZP Li et al.
HEPATOLOGY (2003)
Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis
M Chiva et al.
JOURNAL OF HEPATOLOGY (2002)
Short-chain fatty acids and human colonic function: Roles of resistant starch and nonstarch polysaccharides
DL Topping et al.
PHYSIOLOGICAL REVIEWS (2001)
The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor α in the pathogenesis of non-alcoholic steatohepatitis
AJ Wigg et al.
GUT (2001)
Share Paper
